Blood Clot Risk May Rise With Some Contraceptives: FDA

Law360, New York (September 27, 2011, 7:47 PM EDT) -- The U.S. Food and Drug Administration said Monday that birth control pills like Bayer AG's Yaz and Yasmin containing a certain synthetic hormone might make consumers more likely to have blood clots compared to users of other pills, according to a preliminary study.

“To put this risk into perspective, if the risk of developing a blood clot among women using other hormonal contraceptives is about six women in 10,000, then the risk of developing a blood clot among women using drospirenone-containing oral contraceptives would be about...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.